Overview

Sphenopalatine Block vs Dexmedetomidine Infusion in Trans Nasal Endoscopic Pituitary Surgery

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-10-01
Target enrollment:
Participant gender:
Summary
Improving pain and surgical field by using sphenopalatine ganglion block and dexmedetomidine in trans-nasal endoscopic pituitary surgery.
Phase:
NA
Details
Lead Sponsor:
Zagazig University
Treatments:
Anesthesia, General
Control Groups
Dexmedetomidine
Sphenopalatine Ganglion Block